We will have limited operations from 15:00 Wednesday 24 December 2025 (AEDT) until Friday 2 January 2026. Find out how to contact us during the holiday period.
Use the filters below to narrow your search.
Filter results
You can narrow down the results using the filters.
Topic
- (-) Labelling and packaging (4)
- Safety monitoring and information (121)
- Compliance and enforcement (32)
- Import and export (28)
- Shortages and supply disruptions (17)
- Sunscreens (7)
- Advertising (6)
- COVID-19 (5)
- Weight loss products (4)
- Breast implant hub (3)
- Manufacturing (3)
- Legislation (2)
- Metal-on-metal hip replacement implants hub (1)
Type of content
Search
1033 result(s) found, displaying 976 to 1000
-
-
Safety alertsConsumers are advised to stop using Hydroxycut products due to reports of serious adverse reactions, including liver toxicity, and to consult their doctor if they have any concerns.
-
Safety alertsBe aware that Hydroxycut products purchased via the internet may be sourced from the US and may contain ingredients which are not permitted in low-risk medicines in Australia
-
Safety alertsWeight loss drug Sibutramine (Reductil) under safety review for cardiovascular risks.
-
Safety alertsWe are advising that there are supply issues with Physeptone (methadone) tablets due to quality control problems.
-
Safety alertsApproval has been granted for the Panvax H1N1 vaccine in children starting at 6 months, with Panvax H1N1 Junior for ages 6 months to 3 years.
-
Safety alertsIn October 2009 an anaphylactic reaction to the Panvax H1N1 pandemic influenza vaccine was reported in Western Australia in a person known to have a pre-existing latex allergy.
-
Safety alerts
-
-
Safety alertsGinkgo biloba products with high quercetin and rutin levels have been identified. Quality standards are being reviewed.
-
Safety alertsPanvax H1N1 influenza vaccine has been approved for use in adults and children over 10 years old, with additional data needed for younger children.
-
Safety alertsAdvise to exercise caution when using Australian Hydroxycut products
-
Market actionsChuan Xiong Cha Tiao Wan pills have been recalled due to the presence of aristolochic acids, which can cause severe kidney damage and urinary tract cancer. Stop using them immediately and consult your doctor for advice.
-
Market actions
-
Market actions
-
-
-
-
-
Market actionsA number of brands of hot/cold gel packs are being recalled following testing by the Therapeutic Goods Administration (TGA) of contents for ethylene glycol, a toxic substance.
-
Market actionsA number of brands of hot/cold gel packs are being recalled following testing by the Therapeutic Goods Administration (TGA) of contents for ethylene glycol, a toxic substance. Testing was undertaken following the previous recall of Thermoskin® hot/cold gel packs to determine if the problem was more widespread.
-
Market actionsThe Therapeutic Goods Administration (TGA) advised on 2 September 2008 that the Thermoskin® brand of hot/cold gel packs was being recalled after testing revealed that they contained the toxic substance ethylene glycol, rather than the non-toxic ingredient propylene glycol.
-
Safety alerts
-
Safety alerts
-
Market actionsClexane (enoxaparin) is being recalled due to contamination concerns, and patients should check with their doctor or pharmacist to see if their supply is affected.